Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.
about
From plasmids to protection: a review of DNA vaccines against infectious diseasesProtective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skinConstruction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.Highly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity.Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaAImmunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoInduction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen.Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliveryEnhanced Delivery of DNA or RNA Vaccines by Electroporation.DNA Vaccines Against Maedi-Visna Virus.Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
P2860
Q28250092-B21B04A3-AD20-4E8F-80DB-468A92B1F940Q30360232-D0C8D37F-7905-4B0D-80A3-ACF38079723EQ30395101-6F32233E-9DDC-4F89-8388-2DF014F2EEEEQ33576984-A3190360-62F3-49CB-A0C0-59140A450FFBQ33723334-0E90B7E5-4432-4505-A280-6066CCEBEB4BQ33787778-97CF037B-A3B5-4E78-8062-DB3C9136F033Q33843297-A801097E-722B-4E3D-AA84-9C2090D24B4EQ33897405-DC410B48-55B7-4368-A5D8-833787D05E9AQ34382425-1878B193-9774-43B4-AB71-651228A38D7DQ35049821-55AD305F-614C-4334-9EB3-2C761E35D279Q35082880-C2DEC690-0759-478F-A77C-B30C95E06C87Q35771332-822070C0-63FA-410A-8904-1506D5F6D9ECQ35771342-1F0B4953-A300-48BC-A776-3CA015FE9A44Q35826774-A55C4B96-3AB1-4AC0-81CE-F393C7F6C7B9Q37070349-3EF1CF5E-EBA6-4525-8E6F-80F70FCB8709Q40420214-B72A498D-7ED0-44D6-87E0-27153C143BFEQ40715606-E6F80B63-005B-4A80-8723-7F25C690325CQ42410705-831FCEE1-9D36-4B5C-A36E-551CC7A874BCQ45874869-2EA96920-C0C2-4E86-B658-7F32D74E831AQ50220559-8BD80F33-91BC-4D11-821B-E3F96B45E299Q53272516-BDA98A8C-CADE-46F5-951E-86D007B5CC9B
P2860
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@ast
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@en
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@nl
type
label
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@ast
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@en
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@nl
prefLabel
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@ast
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@en
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@nl
P2093
P1433
P1476
Novel engineered HIV-1 East Af ...... ated immune responses in vivo.
@en
P2093
Andrew Y Choo
Daniel S Hwang
David B Weiner
Donghui Zhang
Jean D Boyer
Karuppiah Muthumani
Nathanael S Dayes
Sandra A Calarota
P304
P356
10.1016/S0042-6822(03)00459-8
P407
P577
2003-09-01T00:00:00Z